New nasal spray offers hope for Treatment-Resistant depression

NCT ID NCT07053345

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 29 times

Summary

This study tests how well esketamine nasal spray works for Korean adults with depression that hasn't improved with other treatments. About 47 participants will use the spray and be monitored for 4 weeks. The main goal is to see if their depression symptoms get better, as measured by a standard depression scale.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, TREATMENT-RESISTANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asan Medical Center

    RECRUITING

    Seoul, 05505, South Korea

  • Cha Ilsan Medical Center

    RECRUITING

    Goyang Si Gyeonggi Do, 10414, South Korea

  • Kangbuk Samsung Hospital

    RECRUITING

    Seoul, 03181, South Korea

  • Kyung Hee University Hospital

    RECRUITING

    Seoul, 130 050, South Korea

  • Samsung Medical Center

    RECRUITING

    Seoul, 06351, South Korea

  • Wonkwang University Hospital

    RECRUITING

    Iksan, 570 711, South Korea

Conditions

Explore the condition pages connected to this study.